{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:38:37Z","timestamp":1790717917393,"version":"4.1.0"},"reference-count":179,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474494"],"award-info":[{"award-number":["82474494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3500102"],"award-info":[{"award-number":["2022YFC3500102"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myocardial infarction (MI) initiates a biphasic immune response, which plays a critical role in determining whether the heart undergoes adaptive repair or progresses to pathological fibrosis. Traditional drug and gene therapy delivery systems have been insufficient in precisely modulating this intricate sequence of events in both temporal and spatial dimensions. In recent years, nucleoside-modified messenger RNA (mRNA) technology, encapsulated within lipid nanoparticles (LNPs), has emerged as a novel platform for delivering transient, non-integrating, and repeatable immune modulation to the injured heart. This article will explore recent interdisciplinary advancements in mRNA technology and cardiac immunology from five distinct perspectives. (i) Strategies for mRNA design, encompassing nucleoside modifications and purification techniques, are primarily aimed at circumventing detection by innate immune sensors within inflamed myocardial tissue; (ii) The concept of trained immunity is investigated, focusing on how transient expression of mRNA encoding epigenetic editors may potentially erase pathological epigenetic imprints in myeloid progenitor cells; (iii) Immune cell reprogramming is examined, addressing the myeloid lineage through macrophage polarization and the degradation of neutrophil extracellular traps via metabolic and transcriptional reprogramming, as well as the lymphoid lineage through transient CAR-T cells, in situ-induced regulatory T cells, and regulatory B cells, with an emphasis on the role of cardiomyocytes as paracrine signaling hubs; (iv) The optimization of lipid nanoparticle (LNP) delivery technology is discussed, including SORT-based organ-targeting strategies and the immunogenicity challenges faced by lipid carriers in ischemic tissues, alongside the development of next-generation self-amplifying RNA payloads; (v) Standards for clinical translation are outlined, involving representative pipelines such as AZD8601 and mRNA-0184, strategies for repeated dosing from an immunological perspective, and the use of biomarkers to guide precision dosing timing. In conclusion, we propose an innovative framework that integrates spatial transcriptomics, gender-stratified dosing strategies, and multi-mRNA formulation technology, with the objective of establishing a viable pathway for personalized cardiac immune reprogramming.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1873905","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:44:28Z","timestamp":1780983868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo immune engineering via mRNA therapeutics: reprogramming the post-infarction cardiac microenvironment"],"prefix":"10.3389","volume":"17","author":[{"given":"Yiying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang\u2019anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guancheng","family":"Ye","sequence":"additional","affiliation":[{"name":"Graduate School, Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Medicine, Tsinghua University","place":["Beijing, China"]},{"name":"Yuquan Hospital, Tsinghua University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325330","article-title":"Gene editing therapy as a therapeutic approach for cardiovascular diseases in animal models: a scoping review","volume":"20","author":"Vo","year":"2025","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade1105","article-title":"Ablation of CaMKII\u03b4 oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease","volume":"379","author":"Lebek","year":"2023","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2024.101273","article-title":"Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies","volume":"32","author":"Chhabra","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/cvr\/cvv205","article-title":"Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation","volume":"108","author":"Rincon","year":"2015","journal-title":"Cardiovasc Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112884","article-title":"Self-amplifying RNA approach for protein replacement therapy","volume":"23","author":"Papukashvili","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1126\/science.adu9394","article-title":"Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction","volume":"391","author":"Zhang","year":"2026","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signaling in cardiac ischemia","volume":"8","author":"Arslan","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr695","article-title":"Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA","volume":"39","author":"Karik\u00f3","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J Control Release"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx135","article-title":"N1-methyl-pseudouridine in mRNA enhances translation through eIF2\u03b1-dependent and independent mechanisms by increasing ribosome density","volume":"45","author":"Svitkin","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00027-06","article-title":"Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action","volume":"70","author":"Garc\u00eda","year":"2006","journal-title":"Microbiol Mol Biol Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.39","article-title":"Cap 1 messenger RNA synthesis with co-transcriptional CleanCap\u00ae analog by in vitro transcription","volume":"1","author":"Henderson","year":"2021","journal-title":"Curr Protoc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.12.011","article-title":"Improving mRNA-based therapeutic gene delivery by expression-augmenting 3' UTRs identified by cellular library screening","volume":"27","author":"Orlandini von Niessen","year":"2019","journal-title":"Mol Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015024","article-title":"Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells","volume":"108","author":"Holtkamp","year":"2006","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07806-1","article-title":"Spatially clustered type I interferon responses at injury borderzones","volume":"633","author":"Ninh","year":"2024","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108658","article-title":"The selective STING inhibitor H-151 preserves myocardial function and ameliorates cardiac fibrosis in murine myocardial infarction","volume":"107","author":"Hu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","article-title":"Western diet triggers NLRP3-dependent innate immune reprogramming","volume":"172","author":"Christ","year":"2018","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","article-title":"Modulation of myelopoiesis progenitors is an integral component of trained immunity","volume":"172","author":"Mitroulis","year":"2018","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad787","article-title":"Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis","volume":"45","author":"Dong","year":"2024","journal-title":"Eur Heart J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac113","article-title":"Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction","volume":"119","author":"Rizzo","year":"2023","journal-title":"Cardiovasc Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","article-title":"Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction","volume":"20","author":"Dick","year":"2019","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1406508111","article-title":"Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart","volume":"111","author":"Lavine","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103992","article-title":"Inflammation and resolution signaling in cardiac repair and heart failure","volume":"79","author":"Halade","year":"2022","journal-title":"EBioMedicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIRCRESAHA.108.188243","article-title":"IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR","volume":"104","author":"Krishnamurthy","year":"2009","journal-title":"Circ Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmccpl.2026.100850","article-title":"Spatio-temporal targeting of cardiac cells with lipid nanoparticles after myocardial infarction","volume":"16","author":"Harper","year":"2026","journal-title":"J Mol Cell Cardiol Plus"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw002","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur Heart J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636954","article-title":"Neutrophil extracellular traps activate proinflammatory functions of human neutrophils","volume":"12","author":"D\u00f6mer","year":"2021","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","article-title":"A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-514992","article-title":"VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice","volume":"123","author":"Savchenko","year":"2014","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110274","article-title":"Macrophage heterogeneity in myocardial infarction: Evolution and implications for diverse therapeutic approaches","volume":"27","author":"Kanuri","year":"2024","journal-title":"iScience"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-024-01260-0","article-title":"Immunometabolic cues recompose and reprogram the microenvironment around implanted biomaterials","volume":"8","author":"Maduka","year":"2024","journal-title":"Nat BioMed Eng"},{"key":"B61","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","article-title":"Krebs cycle reborn in macrophage immunometabolism","volume":"38","author":"Ryan","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-022-10290-5","article-title":"The role of regulatory T cells in heart repair after myocardial infarction","volume":"16","author":"Wang","year":"2023","journal-title":"J Cardiovasc Transl Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046789","article-title":"A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction","volume":"142","author":"Xia","year":"2020","journal-title":"Circulation"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"B67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.015","article-title":"Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms","volume":"42","author":"Spangler","year":"2015","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10495-017-1438-3","article-title":"SDF-1 induces TNF-mediated apoptosis in cardiac myocytes","volume":"23","author":"Jarrah","year":"2018","journal-title":"Apoptosis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","article-title":"Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation","volume":"115","author":"Weirather","year":"2014","journal-title":"Circ Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3284","article-title":"B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction","volume":"19","author":"Zouggari","year":"2013","journal-title":"Nat Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101323","article-title":"IL-10-producing regulatory B cells and plasmocytes: Molecular mechanisms and disease relevance","volume":"44","author":"Cerqueira","year":"2019","journal-title":"Semin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.004408","article-title":"Deleterious effect of the IL-23\/IL-17A axis and \u03b3\u03b4T cells on left ventricular remodeling after myocardial infarction","volume":"1","author":"Yan","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00634","article-title":"Non-cytotoxic cardiac innate lymphoid cells are a resident and quiescent type 2-commited population","volume":"10","author":"Bracamonte-Baran","year":"2019","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.034","article-title":"Clinical development of therapeutic mRNA applications","volume":"33","author":"\u017bak","year":"2025","journal-title":"Mol Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2018.04.003","article-title":"Biocompatible, purified VEGF-A mRNA improves cardiac function after intracardiac injection 1 week post-myocardial infarction in swine","volume":"9","author":"Carlsson","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"17509","DOI":"10.1038\/s41598-018-35570-6","article-title":"Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing","volume":"8","author":"Sun","year":"2018","journal-title":"Sci Rep"},{"key":"B81","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.ircmb.2016.09.007","article-title":"Immunomodulatory activity of VEGF in cancer","volume":"330","author":"Lapeyre-Prost","year":"2017","journal-title":"Int Rev Cell Mol Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflammation Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0042-1","article-title":"Regenerating the field of cardiovascular cell therapy","volume":"37","author":"Chien","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol Ther"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach","volume":"22","author":"Haghighi","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","article-title":"Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA","volume":"11","author":"Patel","year":"2020","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2020.05.030","article-title":"Synthetic mRNA encoding VEGF-A in patients undergoing coronary artery bypass grafting: Design of a phase 2a clinical trial","volume":"18","author":"Anttila","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.304346","article-title":"Meta-analysis of cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data","volume":"116","author":"Gy\u00f6ngy\u00f6si","year":"2015","journal-title":"Circ Res"},{"key":"B92","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/mt.2015.193","article-title":"Myocardial delivery of lipidoid nanoparticle carrying modRNA induces rapid and transient expression","volume":"24","author":"Turnbull","year":"2016","journal-title":"Mol Ther"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.04.018","article-title":"Cardiac delivery of modified mRNA using lipid nanoparticles: Cellular targets and biodistribution after intramyocardial administration","volume":"369","author":"Labonia","year":"2024","journal-title":"J Control Release"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c00958","article-title":"Modulating plaque inflammation via targeted mRNA nanoparticles for the treatment of atherosclerosis","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.11.017","article-title":"Direct intramyocardial injection of VEGF mRNA in patients undergoing coronary artery bypass grafting","volume":"31","author":"Anttila","year":"2023","journal-title":"Mol Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202403935","article-title":"Membrane fusion-mediated loading of therapeutic siRNA into exosome for tissue-specific application","volume":"36","author":"Xie","year":"2024","journal-title":"Adv Mater"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70201","article-title":"Hybrid extracellular vesicles for efficient loading and functional delivery of mRNA","volume":"14","author":"Wang","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-022-01071-x","article-title":"Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines","volume":"17","author":"Szebeni","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.05.007","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"55","author":"Alameh","year":"2022","journal-title":"Immunity"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"IScience"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol Ther"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat BioMed Eng"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14155","article-title":"Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges","volume":"175","author":"Huang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002741","article-title":"Enhancing early mortality prediction for sepsis-associated acute respiratory distress syndrome patients via optimized machine learning algorithm: development and multiple databases' validation of the SAFE-Mo","volume":"111","author":"Jiang","year":"2025","journal-title":"Int J Surg"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/biom16040505","article-title":"The complement system in the setting of critical illness-a narrative review","volume":"16","author":"Ampelakiotou","year":"2026","journal-title":"Biomolecules"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol Ther"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.003","article-title":"Development of anti-PEG IgG\/IgM\/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy","volume":"366","author":"Li","year":"2024","journal-title":"J Control Release"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal Chem"},{"key":"B113","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bioactmat.2024.03.017","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact Mater"},{"key":"B114","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jconrel.2014.07.049","article-title":"Extracellular vesicles as drug delivery systems: lessons from the liposome field","volume":"195","author":"van der Meel","year":"2014","journal-title":"J Control Release"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1159\/000438594","article-title":"Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation","volume":"37","author":"Teng","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114068","article-title":"Molecular engineering of extracellular vesicles for drug delivery: strategies, challenges, and perspectives","volume":"386","author":"Dave","year":"2025","journal-title":"J Control Release"},{"key":"B117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12951-018-0388-4","article-title":"Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display","volume":"16","author":"Antes","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/polym16172536","article-title":"Biodegradable polymeric nanoparticle-based drug delivery systems: comprehensive overview, perspectives and challenges","volume":"16","author":"Geszke-Moritz","year":"2024","journal-title":"Polymers (Basel)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202500971","article-title":"Design and validation of hybrid polymer-lipid nanoparticles as novel transfection vectors for microRNA delivery to human cardiac fibroblasts","volume":"14","author":"Nicoletti","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol Ther"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c09677","article-title":"Amplification of protein expression by self-amplifying mRNA delivered in lipid nanoparticles containing a \u03b2-aminoester ionizable lipid correlates with reduced innate immune activation","volume":"18","author":"De Lombaerde","year":"2024","journal-title":"ACS Nano"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol Ther"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.11.011","article-title":"Innate inhibiting proteins enhance expression and immunogenicity of self-amplifying RNA","volume":"29","author":"Blakney","year":"2021","journal-title":"Mol Ther"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.09.009","article-title":"A trans-amplifying RNA vaccine strategy for induction of potent protective immunity","volume":"28","author":"Beissert","year":"2020","journal-title":"Mol Ther"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115461","article-title":"Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids","volume":"215","author":"Bader","year":"2024","journal-title":"Adv Drug Delivery Rev"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20240109","article-title":"Extracellular vesicle-based mRNA therapeutics and vaccines","volume":"5","author":"Li","year":"2025","journal-title":"Exploration"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123541","article-title":"Biodegradable polymers with tertiary amines enhance mRNA delivery of lipid nanoparticles via improved endosomal escape","volume":"324","author":"Zhao","year":"2026","journal-title":"Biomaterials"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.02.035","article-title":"Locally delivered hydrogels with controlled release of nanoscale exosomes promote cardiac repair after myocardial infarction","volume":"368","author":"Tan","year":"2024","journal-title":"J Control Release"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2024.2409906","article-title":"Hydrogel formulations for orthotopic treatment of myocardial infarction","volume":"21","author":"Luo","year":"2024","journal-title":"Expert Opin Drug Delivery"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020131","article-title":"CRISPR-Cas9 in cardiovascular medicine: unlocking new potential for treatment","volume":"14","author":"Bonowicz","year":"2025","journal-title":"Cells"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13894","article-title":"Translational pharmacokinetic\/pharmacodynamic model for mRNA-0184, an investigational therapeutic for the treatment of heart failure","volume":"17","author":"Kaushal","year":"2024","journal-title":"Clin Transl Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/ehjcvp\/pvad103","article-title":"VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients","volume":"10","author":"Horie","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04254-4","article-title":"In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial","volume":"32","author":"Wan","year":"2026","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107847","article-title":"Messenger RNA (mRNA) based therapeutics in transforming cardiovascular care: progress, regulatory challenges and future perspectives","volume":"218","author":"Khan","year":"2025","journal-title":"Pharmacol Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0000000000001210","article-title":"RNA therapeutics in cardiovascular medicine","volume":"40","author":"Damase","year":"2025","journal-title":"Curr Opin Cardiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","article-title":"VEGFA mRNA for regenerative treatment of heart failure","volume":"21","author":"Coll\u00e9n","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801291","article-title":"Effects of serelaxin in patients with acute heart failure","volume":"381","author":"Metra","year":"2019","journal-title":"N Engl J Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.04.011","article-title":"Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: appearance of an unexplained mechanism in the ABC phenomenon","volume":"323","author":"El Sayed","year":"2020","journal-title":"J Control Release"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115044","article-title":"The interplay between PEGylated nanoparticles and blood immune system","volume":"200","author":"Guo","year":"2023","journal-title":"Adv Drug Delivery Rev"},{"key":"B144","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/s41467-018-06621-3","article-title":"Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration","volume":"9","author":"Meliani","year":"2018","journal-title":"Nat Commun"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202524097","article-title":"Nanoparticle-based tolerogenic vaccines: next-generation strategies for autoimmune and allergic disease therapies","volume":"65","author":"Nachod","year":"2026","journal-title":"Angew Chem Int Ed Engl"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073218","article-title":"Cardiovascular biomarkers: tools for precision diagnosis and prognosis","volume":"26","author":"Netala","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.01.068","article-title":"Therapeutic targets in heart failure: refocusing on the myocardial interstitium","volume":"63","author":"Schelbert","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.05.026","article-title":"Molecular imaging of myocardial inflammation with positron emission tomography post-ischemia: a determinant of subsequent remodeling or recovery","volume":"11","author":"Thackeray","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41467-018-03961-y","article-title":"Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA","volume":"9","author":"Zemmour","year":"2018","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","article-title":"Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease","volume":"3","author":"Corsten","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"B151","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","article-title":"Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-00794-6","article-title":"Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction","volume":"45","author":"Bawamia","year":"2023","journal-title":"GeroScience"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2022.2038539","article-title":"Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review","volume":"59","author":"Notarte","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B155","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.tcm.2022.01.004","article-title":"MicroRNA-mediated control of myocardial infarction in diabetes","volume":"33","author":"P\u00e9rez-Cremades","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"26503","DOI":"10.1038\/s41598-024-78553-6","article-title":"Multimodal AI\/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases","volume":"14","author":"DeGroat","year":"2024","journal-title":"Sci Rep"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08008-5","article-title":"Targeting immune-fibroblast cell communication in heart failure","volume":"635","author":"Amrute","year":"2024","journal-title":"Nature"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1974289","article-title":"Time and cost of administering COVID-19 mRNA vaccines in the United States","volume":"17","author":"Yarnoff","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00010","article-title":"Current status and future perspectives on mRNA drug manufacturing","volume":"19","author":"Webb","year":"2022","journal-title":"Mol Pharm"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091371","article-title":"Pharma 4.0 continuous mRNA drug products manufacturing","volume":"13","author":"Ouranidis","year":"2021","journal-title":"Pharmaceutics"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/nano16040268","article-title":"Identifying key factors affecting mRNA-lipid nanoparticles drug product formulation stability","volume":"16","author":"Nomani","year":"2026","journal-title":"Nanomaterials (Basel)"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00956","article-title":"Investigations into mRNA lipid nanoparticles shelf-life stability under nonfrozen conditions","volume":"20","author":"Reinhart","year":"2023","journal-title":"Mol Pharm"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.02.001","article-title":"Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine","volume":"30","author":"Muramatsu","year":"2022","journal-title":"Mol Ther"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1039\/d2bm02031a","article-title":"Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids","volume":"11","author":"Lamoot","year":"2023","journal-title":"Biomater Sci"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/rb\/rbaf023","article-title":"Development of lyophilized mRNA-LNPs with high stability and transfection efficiency in specific cells and tissues","volume":"12","author":"Wang","year":"2025","journal-title":"Regener Biomater"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2354251","article-title":"Research progress on the quality control of mRNA vaccines","volume":"23","author":"Hu","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2025.465724","article-title":"Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods","volume":"1745","author":"Webb","year":"2025","journal-title":"J Chromatogr A"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014035","article-title":"Synthetic chemically modified mRNA (modRNA): toward a new technology platform for cardiovascular biology and medicine","volume":"5","author":"Chien","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B169","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat Commun"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1129348","article-title":"Sex and gender differences in myocarditis and dilated cardiomyopathy: An update","volume":"10","author":"Fairweather","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00797-4","article-title":"Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes","volume":"20","author":"Regitz-Zagrosek","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506121","article-title":"Adipose tissue macrophages as initiators of exacerbated periodontitis in estrogen-deficient environments via the amplifier extracellular vesicles","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05060-x","article-title":"Spatial multi-omic map of human myocardial infarction","volume":"608","author":"Kuppe","year":"2022","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.125.074959","article-title":"Single-cell splicing isoform atlas of the adult human heart and heart failure","volume":"152","author":"Pan","year":"2025","journal-title":"Circulation"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0077-x","article-title":"The interstitium in cardiac repair: role of the immune-stromal cell interplay","volume":"15","author":"Forte","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.02.003","article-title":"Systemic mRNA therapy for the treatment of Fabry disease: preclinical studies in wild-type mice, Fabry mouse model, and wild-type non-human primates","volume":"104","author":"Zhu","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1002\/amp2.10060","article-title":"Rapid development and deployment of high-volume vaccines for pandemic response","volume":"2","author":"Kis","year":"2020","journal-title":"J Adv Manuf Process"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873905\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:44:30Z","timestamp":1780983870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1873905\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":179,"alternative-id":["10.3389\/fimmu.2026.1873905"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1873905","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1873905"}}